Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy

Clinical trial NCT05111860 · UNKNOWN

Trial details

NCT number: NCT05111860
Sponsor: Shanghai Minimally Invasive Surgery Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoadjuvant Treatment Rectal Cancer Bevacizumab Radiotherapy

Start date: 2022-11-01
Primary completion: 2024-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.